2021 COCA Calls/Webinars Information, Summaries, & Slide Sets
Title: Updated Guidance for Clinicians on COVID-19 Vaccines
Date: Friday, December 17, 2021
Presenters:
Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Isaac See, MD
Vaccine Safety Team
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Date: Thursday, December 9, 2021
Presenters:
Manish Patel, MD, MSc
Team Lead, Influenza Prevention and Control Team
Influenza Division
Centers for Disease Control and Prevention
John Barnes, PhD
Team Lead, Strain Surveillance and Emerging Variants
COVID-19 Response
Centers for Disease Control and Prevention
Alison Laufer Halpin, PhD
CDR, U.S. Public Health Service
Task Force Lead, Laboratory and Testing Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Date: Thursday, November 18, 2021
Presenters:
Lauri Hicks, DO
CAPT, U.S. Public Health Service
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Christopher Evans, PharmD
Healthcare Associated Infections and
Antimicrobial Resistance Program
Tennessee Department of Health
Jeffrey Gerber, MD, PhD
Associate Professor of Pediatrics and Epidemiology
University of Pennsylvania School of Medicine
Division of Infectious Diseases
Children’s Hospital of Philadelphia
Payal Patel, MD, MPH
Assistant Professor, Division of Infectious Diseases,
University of Michigan Health System
Medical Director of Antimicrobial Stewardship,
VA Ann Arbor Healthcare System
Date: Thursday, November 4, 2021
Presenters:
Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19
Vaccines Work Group
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Kate Woodworth, MD, MPH, FAAP
Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Kevin Chatham-Stephens, MD, MPH, FAAP
CDR, U.S. Public Health Service
Pediatric Vaccine Readiness and Implementation Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know about the Recent Updates to CDC’s Recommendations for COVID-19 Boosters
Date: Tuesday, October 26, 2021
Presenters:
Anne Hause, PhD
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Kathleen Dooling, MD, MPH
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Sujan Reddy, MD, MSc
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Date: Thursday, October 7, 2021
Presenters:
David Shay, MD
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Flor Munoz, MD, MSc, FAAP
Associate Professor of Pediatrics, Infectious Diseases, and Molecular Virology and Microbiology
Baylor College of Medicine
Title: Evaluating and Supporting Patients Presenting With Fatigue Following COVID-19
Date: Thursday, September 30, 2021
Presenters:
Maureen Miller, MD, MPH
Research, Surveillance, and Management Unit
Natural History/Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Joseph E. Herrera, DO
Professor and System Chair of Rehabilitative Medicine
Department of Rehabilitation and Physical Medicine
Mount Sinai Health System
Monica Verduzco Gutierrez, MD
Professor and Chair of Physical Medicine and Rehabilitation
Department of Physical Medicine and Rehabilitation
UT Health San Antonio
Benjamin Abramoff, MD, MS
Assistant Professor of Clinical Physical Medicine and Rehabilitation
Department of Physical Medicine and Rehabilitation
Penn Medicine
Date: Tuesday, September 28, 2021
Presenters:
Dr. Ruth Link-Gelles, PhD, MPH
Co-lead COVID-19 Vaccine Effectiveness Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Dr. Anne Hause, PhD, MSPH
Co-Lead V-safe Team
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Dr. Neela Goswami, MD, MPH
Lead Clinical Guidelines Team
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Date: Thursday, September 09, 2021
Presenters:
CAPT Lisa Grohskopf, MD, MPH
Medical Officer, Influenza ACIP Lead
Epidemiology and Prevention Branch
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Andrew Kroger, MD, MPH
Medical Officer
Communication and Education Branch
Immunization Services Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Title: Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People
Date: Tuesday, August 17, 2021
Presenters:
Kathleen Dooling, MD, MPH
ACIP Workgroup Team Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Neela Goswami, MD, MPH
Clinical Guidelines Team Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Katherine Shealy, MPH, IBCLC
Vaccine Clinical Inquiry Management Team Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Title: Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People
Date: Thursday, August 12, 2021
Presenters:
Elliot Raizes, MD
Task Force Lead
Health Services and Worker Safety Task Force
COVID-19 Response
Centers for Disease Control and Prevention
John Farley, MD, MPH
Director, Office of Infectious Diseases
Center for Drug Evaluation and Research
Office of New Drugs
U.S. Food and Drug Administration
Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention
Rajesh Gandhi, MD
Director, HIV Clinical Services and Education, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School
Adi V. Gundlapalli, MD, PhD
Co-Lead, Serology and Correlates of Protection Tiger Team, COVID-19 Response
Chief Public Health Informatics Officer
Center for Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention
Title: Evaluating and Caring for Patients with Post-COVID Conditions
Date: Thursday, June 17, 2021
Presenters:
Jennifer R. Chevinsky, MD, MPH
Epidemic Intelligence Service Officer
Post-COVID-19 Conditions Unit
COVID-19 Response
Centers for Disease Control and Prevention
Alex Vosooney, MD
Chair, Subcommittee on Clinical Recommendations and Policies
American Academy of Family Physicians
Michael Saag, MD
Professor of Medicine
Director, UAB Center for AIDS Research
University of Alabama Birmingham
Title: Underlying Medical Conditions and Severe COVID-19: Evidence-based Information for Healthcare Providers
Date: Thursday, May 27, 2021
Presenters:
Kanta Sircar, PhD, MPH
Clinical Disease Team
COVID-19 Response
Centers for Disease Control and Prevention
John Brooks, MD, MPH
Chief Medical Officer
COVID-19 Response
Centers for Disease Control and Prevention
Sapna Bamrah Morris, MD, MBA
Clinical Disease Team Lead
Health Systems and Worker Safety Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Title: Lyme Disease Updates and New Educational Tools for Clinicians
Date: Thursday, May 20, 2021
Presenters:
Grace Marx, MD, MPH
LCDR, U.S. Public Health Service
Medical Epidemiologist, Bacterial Diseases Branch
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents
Date: Friday, May 14, 2021
Presenters:
Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Kate Woodworth, MD, MPH
Medical Officer, Clinical Guidance Team
COVID-19 Response
Centers for Disease Control and Prevention
Tanya Myers, PhD, MSc
v-safe Team Co-Lead
COVID-19 Response
Centers for Disease Control and Prevention
Title: Johnson & Johnson/Janssen COVID-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS): Update for Clinicians
Date: Tuesday, April 27, 2021
Presenters:
Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention
Title: Johnson & Johnson/Janssen COVID-19 Vaccine and Cerebral Venous Sinus Thrombosis with Thrombocytopenia – Update for Clinicians on Early Detection and Treatment
Date: Thursday, April 15, 2021
Presenters:
Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention
Title: The Role of Telehealth in Expanding Access to Healthcare During the COVID-19 Pandemic: Considerations for Vaccine Uptake and Monitoring for Adverse Events
Date: Thursday, March 11, 2021
Presenters:
Erica Tindall, MSN, MPH, APRN, AGNP-C, CIC
Public Health Analyst, Senior Health Research Analyst
Peraton
Ann Mond Johnson
CEO
American Telemedicine Association
Michelle Rizor, MHSA
Principal, Strategic Partnerships – Virtual Health
Spectrum Health
Daniel Smith, PA-C
Lead Provider Informaticist
Spectrum Health
Todd Vento, MD, MPH, FACP, FIDSA
Medical Director, Infectious Diseases & Specialty TeleHealth
Intermountain Healthcare
Title: What Every Clinician Should Know about COVID-19 Vaccine Safety and Effectiveness and How to Address Patient Questions and Concerns
Date: Tuesday, March 09, 2021
Presenters:
Tom Shimabukuro, MD, MPH, MBA
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention
Kathleen Dooling, MD, MPH
Medical Officer
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Stephen Perez, RN, PhD
LT, U.S Public Health Service
Clinical Lead, Vaccine Confidence Team
COVID-19 Response
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know About Johnson & Johnson’s Janssen COVID-19 Vaccine
Date: Tuesday, March 02, 2021
Presenters:
Sarah Mbaeyi, MD, MPH
CDR, U.S. Public Health Service
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Kathleen Dooling, MD, MPH
Medical Officer
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Title: Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care
Date: Thursday, January 28, 2021
Presenters:
Alfonso C Hernandez-Romieu, MD, MPH
LCDR, U.S. Public Health Service
Late Sequelae Unit, Clinical Team
COVID-19 Response
Centers for Disease Control and Prevention
Jennifer Possick, MD
Associate Professor, Section of Pulmonary, Critical Care and Sleep Medicine
Department of Internal Medicine
Yale University School of Medicine
Allison Navis, MD
Assistant Professor, Division Neuro-Infectious Diseases
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System